Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
2000-08-29
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, 514274, 514 16, 514 17, 514 18, 514 19, A61K 3152, A61K 31505, A61K 3800
Patent
active
061109231
ABSTRACT:
The present invention covers a method of treatment of cancer, in particular, colon carcinoma, comprising the step of administering the compound N2-(6-dimethylamino purin-9-yl)-7-pentyloxycarbonyl-L-arginine in combination with 5-fluorouracil. The present invention also covers pharmaceutical composition containing these two compounds for the treatment of cancer.
REFERENCES:
patent: 3165520 (1965-01-01), Schmidt et al.
patent: 4567182 (1986-01-01), Ferraris
patent: 4602089 (1986-07-01), Simon et al.
patent: 4663326 (1987-05-01), Hamilton
patent: 4694006 (1987-09-01), Bundgaard et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5214048 (1993-05-01), Shimada
patent: 5272151 (1993-12-01), Marzi et al.
patent: 5332744 (1994-07-01), Chakravarty
Carter et al., Chemotherapy of Cancer, 2.sup.nd ED, John Wiley & Sons, WY. WY. (1981) pp. 362-365.
Il Farmaco (1990, vol. 45 entitled "Synthetic Biological Response Modifiers"; Part 1. Synthesis and Immunomodulatory Properties of Some N-(w-Hypoxanthin-9-YL) Alkoxycarbonyl)-L-Argines; Authors: R. Stradi, E. Rossi, L. Perezzani, G. Migliorati, C. Riccardi, P. Cornaglia-Ferraris; pp. 39-47.
Int. J. Immunopharmac, vol. 13, No. 7 (1991) entitled "Short Communication, A New Peptide Analog (RM06) Modulates the Growth of Hematopoietic Cells"; Authors: P. Cornaglia-Ferraris, A. Biano, M.V. Corrias, R. Stradi; pp. 1005-1012.
Journal of Biological Response Modifiers (1990), vol. 9 entitled "Antiviral Activity of the Novel Immune Modulator 7-Thia-8-Oxoguanosine"; Authors: Donald F. Smee, Hassan A. Alaghamandan, Howard B. Cottam, Weldon B. Jolley, and Roland K. robins; pp. 24-32.
Antiviral Chemistry & Chemotherapy (1991), vol. 2 entitled A study of the Efficacy of the Immunomodulatory Compound 7-Thia-8-Oxoguanosine in Coronavirus 229E Infections in Human Volunteers; Authors: P.G. Higgins, G.I. Barrow, D.A.J. Tyrrell, N.J.C. Snell, K. Jones, W.B. Jolley; pp. 61-63.
Antimicrobial Agents and Chemotherapy (1991), vol. 35 entitled "Immunoenhancing Properties and Antiviral Activity of 7-Deazaguanosine in Mice"; Authors: D. Smee, H.A. Alaghamandan, J. Gilbert, R.A. Burger, A. Jin, B.S. Sharma, K. Ramasamy, G.R. Revankar, H.B. Cottam, W.B. Jolley, R.K. Robins; pp. 152-157.
Int. J. Immunopharmac., vol. 13 (1991), "Methyl Inosine Monophosphate (MIMP), a New Purine Immunomodulator for HIV Infection", Authors: J.W. Hadden, A. Giner-Sorolla, E.M. Hadden; pp. 49-54.
Thymus, vol. 19, "ST789: A New Synthetic Immunomodulator" (1992), Authors: C. De Simone, E. Arrigoni Martelli; pp. S1-S5.
Biochem Pharma Inc.
Goldberg Jerome D.
LandOfFree
Method for treating cancer using novel substituted purinyl deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating cancer using novel substituted purinyl deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cancer using novel substituted purinyl deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1250132